Andrew Lin
CHAIRMAN
Toxicology
Lotus Pharmaceuticals
Taiwan
Biography
Andrew Lin is one of the very few management professionals who owns extensive experience across sellside, buyside, corporate and consulting. He is very familiar with capital markets as prior to joining Lotus, Andrew was the General Manager of JP Morgan Securities, Chief Investment Officer of ABN AMRO Asset Management, and Managing Director of Macquarie Capital Greater China. Andrew has initiated and conducted several large scale IPO, M&A and fund raising cases when he was with the financial giants. On the business strategy side, Andrew served as the Chief Finance Officer of Lite-On Technology and Chief Strategy Officer of Chicony Electronics. He has been known for sound financial structure optimization and market cap expansion when he was with corporates. Mr. Lin received his MBA degree from The University of Chicago, Graduate School of Business. He also graduated with an M.S. degree in electrical and computer engineering from the University of Massachusetts at Amherst.
Research Interest
Finance and Toxicology
